,reactionoutcome,reactionmeddraversionpt,reactionmeddrapt,safetyreportid
0,6,22.0,Syringe issue,16743554
1,6,22.0,Intercepted medication error,16743554
0,6,22.0,Syringe issue,16743556
1,6,22.0,Product leakage,16743556
2,6,22.0,Intercepted medication error,16743556
0,6,22.0,Intercepted medication error,16743557
1,6,22.0,Syringe issue,16743557
0,6,22.0,Product leakage,16743559
1,6,22.0,Intercepted medication error,16743559
0,6,22.0,Intercepted medication error,16743560
1,6,22.0,Product packaging issue,16743560
0,6,22.0,Hyperhidrosis,16743561
1,6,22.0,Hot flush,16743561
2,6,22.0,Erectile dysfunction,16743561
0,6,22.0,Syringe issue,16743562
1,6,22.0,Intercepted medication error,16743562
2,6,22.0,Device defective,16743562
0,6,22.0,Syringe issue,16743564
1,6,22.0,Intercepted medication error,16743564
0,6,22.0,Intercepted medication error,16743566
1,6,22.0,Syringe issue,16743566
2,6,22.0,Wrong technique in product usage process,16743566
0,6,22.0,Product leakage,16743568
1,6,22.0,Intercepted medication error,16743568
0,6,22.0,Product leakage,16743569
1,6,22.0,Intercepted medication error,16743569
2,6,22.0,Syringe issue,16743569
0,5,22.0,Death,16743571
0,6,22.0,Syringe issue,16743573
1,6,22.0,Intercepted medication error,16743573
0,6,22.0,Intercepted medication error,16743574
1,6,22.0,Needle issue,16743574
0,6,22.0,Syringe issue,16743575
1,6,22.0,Intercepted medication error,16743575
2,6,22.0,Device defective,16743575
0,6,22.0,Product leakage,16743576
1,6,22.0,Intercepted medication error,16743576
0,3,22.0,Prostatic specific antigen increased,16743585
1,6,22.0,Wrong technique in product usage process,16743585
0,3,22.0,Pelvic pain,16743586
0,3,22.0,Blood urine present,16743587
1,1,22.0,Dizziness,16743587
2,1,22.0,Dyspnoea,16743587
3,1,22.0,Asthenia,16743587
4,3,22.0,Chromaturia,16743587
0,6,22.0,Malignant neoplasm progression,16743662
1,6,22.0,Product packaging quantity issue,16743662
2,6,22.0,Product blister packaging issue,16743662
3,6,22.0,Poor quality product administered,16743662
0,1,22.0,Vomiting,16743706
1,6,22.0,Weight decreased,16743706
2,1,22.0,Diarrhoea,16743706
3,1,22.0,Nausea,16743706
0,6,22.0,Nausea,16743707
1,6,22.0,Diarrhoea,16743707
2,6,22.0,Brain neoplasm,16743707
3,6,22.0,Sinusitis,16743707
4,6,22.0,Abdominal pain,16743707
5,2,22.0,Memory impairment,16743707
6,5,22.0,Death,16743707
0,6,22.0,Thrombosis,16743708
1,6,22.0,Irritability,16743708
2,6,22.0,Depressed mood,16743708
3,5,22.0,Death,16743708
4,6,22.0,Confusional state,16743708
5,6,22.0,Anger,16743708
6,6,22.0,Rash macular,16743708
7,6,22.0,Photosensitivity reaction,16743708
0,5,22.1,Death,16743718
1,6,22.1,Cerebrovascular accident,16743718
0,6,22.1,Off label use,16743728
1,6,22.1,Product use in unapproved indication,16743728
0,6,22.0,Increased tendency to bruise,16743761
1,6,22.0,Arterial repair,16743761
2,6,22.0,Chronic obstructive pulmonary disease,16743761
3,6,22.0,Myocardial ischaemia,16743761
0,6,22.0,Rash erythematous,16743769
1,6,22.0,Somnolence,16743769
2,6,22.0,Dry skin,16743769
3,6,22.0,Fall,16743769
4,6,22.0,Contusion,16743769
5,3,22.0,Headache,16743769
6,1,22.0,Diarrhoea,16743769
7,2,22.0,Breast cancer metastatic,16743769
8,6,22.0,Gastrooesophageal reflux disease,16743769
9,6,22.0,Amnesia,16743769
10,6,22.0,Abnormal faeces,16743769
11,2,22.0,Decreased appetite,16743769
12,6,22.0,Hospitalisation,16743769
13,3,22.0,Gait disturbance,16743769
14,6,22.0,Pain in extremity,16743769
15,3,22.0,Peripheral swelling,16743769
16,6,22.0,Off label use,16743769
0,6,22.0,Dermatomyositis,16743780
0,6,22.0,Syringe issue,16743840
1,6,22.0,Off label use,16743840
2,6,22.0,Intercepted medication error,16743840
0,6,22.0,Syringe issue,16743841
1,6,22.0,Intercepted medication error,16743841
0,5,22.0,Death,16743857
0,1,22.1,Uterine cancer,16743897
1,6,22.1,Metastases to lung,16743897
0,1,22.1,Febrile neutropenia,16743974
1,6,22.1,Colony stimulating factor therapy,16743974
0,2,22.0,Acute kidney injury,16743979
0,6,22.0,Intestinal obstruction,16744003
0,1,22.1,Application site vesicles,16744015
1,6,22.1,Unintentional medical device removal,16744015
0,6,22.1,Metastases to bone,16744051
1,6,22.1,Metastases to lung,16744051
2,3,22.1,Metastases to skin,16744051
3,6,22.1,Breast cancer metastatic,16744051
4,6,22.1,Malignant neoplasm progression,16744051
5,6,22.1,Tumour marker increased,16744051
6,6,22.1,Metastases to lymph nodes,16744051
0,6,22.0,Periorbital oedema,16744057
0,1,22.0,Toxicity to various agents,16744082
1,6,22.0,Therapy partial responder,16744082
2,1,22.0,Fatigue,16744082
3,6,22.0,Drug ineffective,16744082
4,6,22.0,Neuropathy peripheral,16744082
5,6,22.0,Disease progression,16744082
6,6,22.0,Off label use,16744082
7,6,22.0,Malaise,16744082
0,5,22.1,Lung disorder,16744100
1,6,22.1,Venous thrombosis,16744100
0,6,22.1,Feeling hot,16744170
1,1,22.1,Muscle spasms,16744170
2,6,22.1,Dysphagia,16744170
3,3,22.1,Vomiting,16744170
4,6,22.1,Feeling abnormal,16744170
5,6,22.1,Gastrointestinal pain,16744170
6,3,22.1,Nausea,16744170
7,6,22.1,Decreased appetite,16744170
0,1,22.0,Vomiting,16744175
1,1,22.0,Chest pain,16744175
2,1,22.0,Dyspnoea,16744175
3,1,22.0,Hypertensive crisis,16744175
0,6,22.0,Non-cirrhotic portal hypertension,16744180
1,6,22.0,Liver injury,16744180
2,1,22.0,Confusional state,16744180
3,6,22.0,Hepatic encephalopathy,16744180
0,6,22.0,Blister,16744193
1,6,22.0,Skin ulcer,16744193
0,3,22.0,Abdominal discomfort,16744224
1,3,22.0,Coeliac disease,16744224
0,6,22.0,Radiation pneumonitis,16744309
0,6,22.0,Desmoid tumour,16744335
0,,22.1,Infusion related reaction,16744410
1,,22.1,Drug intolerance,16744410
2,,22.1,Hypertension,16744410
0,1,22.0,Autoimmune haemolytic anaemia,16744417
1,1,22.0,Urinary tract infection,16744417
2,1,22.0,Tremor,16744417
0,3,22.0,Transfusion,16744426
0,5,22.0,Death,16744448
1,6,22.0,Intentional product use issue,16744448
0,3,22.1,Swelling face,16744453
1,6,22.1,Pain in jaw,16744453
2,3,22.1,Feeling abnormal,16744453
3,6,22.1,Hyperaesthesia teeth,16744453
4,6,22.1,Eye pain,16744453
5,6,22.1,Fall,16744453
6,6,22.1,Osteomyelitis,16744453
7,3,22.1,Salivary gland enlargement,16744453
8,6,22.1,Fatigue,16744453
0,3,22.0,Therapeutic product effect incomplete,16744455
0,5,22.0,Disease progression,16744471
0,6,22.0,Dermatomyositis,16744475
0,1,22.0,Haematuria,16744478
0,6,22.0,Product leakage,16744514
1,6,22.0,Syringe issue,16744514
2,6,22.0,Intercepted medication error,16744514
0,6,22.0,Metastases to pelvis,16744518
1,6,22.0,Impatience,16744518
2,3,22.0,Fatigue,16744518
3,6,22.0,Breast pain,16744518
4,3,22.0,Hot flush,16744518
0,6,22.0,Product leakage,16744521
1,6,22.0,Intercepted medication error,16744521
0,6,22.0,Wrong technique in product usage process,16744522
1,6,22.0,Intercepted product preparation error,16744522
0,6,22.0,Needle issue,16744523
1,6,22.0,Intercepted medication error,16744523
0,6,22.0,Intercepted medication error,16744524
1,6,22.0,Product leakage,16744524
2,6,22.0,Wrong technique in product usage process,16744524
0,6,22.0,Product preparation error,16744525
1,6,22.0,Intercepted product preparation error,16744525
2,6,22.0,Product leakage,16744525
0,6,22.0,Intercepted medication error,16744527
1,6,22.0,Syringe issue,16744527
0,6,22.0,Intercepted medication error,16744528
1,6,22.0,Wrong technique in product usage process,16744528
2,6,22.0,Product leakage,16744528
0,6,22.0,Product leakage,16744529
1,6,22.0,Wrong technique in product usage process,16744529
2,6,22.0,Intercepted medication error,16744529
0,1,22.0,Acne,16744535
1,1,22.0,Back pain,16744535
2,1,22.0,Myalgia,16744535
3,1,22.0,Pyrexia,16744535
4,6,22.0,Dizziness,16744535
5,1,22.0,Sleep disorder,16744535
6,2,22.0,Weight decreased,16744535
7,1,22.0,Vertigo,16744535
8,2,22.0,Osteoarthritis,16744535
9,1,22.0,Nasopharyngitis,16744535
10,2,22.0,Diabetes mellitus,16744535
11,1,22.0,Cough,16744535
12,1,22.0,Muscle contracture,16744535
0,6,22.0,Uveitis,16744542
1,6,22.0,Neoplasm progression,16744542
0,5,22.0,Death,16744574
0,5,22.0,Death,16744625
1,6,22.0,Metastases to bone,16744625
0,6,22.0,Metastases to liver,16744632
1,2,22.0,Decreased appetite,16744632
2,6,22.0,Eosinophil count decreased,16744632
3,6,22.0,Blood potassium decreased,16744632
4,6,22.0,Lower respiratory tract infection,16744632
5,6,22.0,Spinal fracture,16744632
6,6,22.0,Haemoglobin decreased,16744632
7,2,22.0,Nausea,16744632
8,2,22.0,Chest pain,16744632
9,6,22.0,Platelet count increased,16744632
10,1,22.0,Skin infection,16744632
11,6,22.0,Neutropenia,16744632
12,6,22.0,Urinary tract infection,16744632
13,6,22.0,General physical health deterioration,16744632
14,6,22.0,Mean cell volume increased,16744632
15,2,22.0,Blood sodium decreased,16744632
16,6,22.0,Diarrhoea,16744632
17,2,22.0,Constipation,16744632
18,6,22.0,Red blood cell count decreased,16744632
19,6,22.0,Hypocalcaemia,16744632
20,6,22.0,Malignant neoplasm progression,16744632
21,6,22.0,White blood cell count decreased,16744632
22,6,22.0,Liver function test abnormal,16744632
23,2,22.0,Lethargy,16744632
24,2,22.0,Malaise,16744632
25,6,22.0,Oral pain,16744632
26,6,22.0,Metastases to bone,16744632
27,6,22.0,Hypercalcaemia,16744632
28,2,22.0,Vomiting,16744632
0,6,22.1,Hypocalcaemia,16744637
1,3,22.1,Immunodeficiency,16744637
2,6,22.1,Weight decreased,16744637
3,3,22.1,Peripheral swelling,16744637
4,3,22.1,Auditory disorder,16744637
5,3,22.1,Hypoacusis,16744637
6,3,22.1,Tooth disorder,16744637
7,3,22.1,Swelling,16744637
8,1,22.1,Cardiac function test abnormal,16744637
9,6,22.1,Hyperhidrosis,16744637
10,3,22.1,Toothache,16744637
0,5,22.0,Death,16744647
0,5,22.0,Neoplasm progression,16744651
1,5,22.0,Oesophageal perforation,16744651
2,5,22.0,Gastrointestinal haemorrhage,16744651
0,5,22.0,Chromaturia,16744653
1,5,22.0,Sweat discolouration,16744653
2,5,22.0,Saliva discolouration,16744653
3,5,22.0,Cardiac failure,16744653
4,5,22.0,Yellow skin,16744653
5,1,22.0,Dyspnoea,16744653
0,1,22.1,Cellulitis,16744654
1,1,22.1,Upper respiratory tract infection,16744654
2,1,22.1,Dental caries,16744654
3,1,22.1,Neutropenia,16744654
0,6,22.0,Hepatic enzyme increased,16744670
1,6,22.0,Hepatitis,16744670
0,6,22.0,Vomiting,16744691
1,6,22.0,Leukopenia,16744691
2,6,22.0,Anaemia,16744691
3,6,22.0,Palmar-plantar erythrodysaesthesia syndrome,16744691
4,6,22.0,Thrombocytopenia,16744691
5,6,22.0,Nausea,16744691
6,6,22.0,Fatigue,16744691
7,6,22.0,Hepatic function abnormal,16744691
8,6,22.0,Neurotoxicity,16744691
9,6,22.0,Renal impairment,16744691
0,6,22.0,Intestinal obstruction,16744742
1,6,22.0,Neutrophil count decreased,16744742
2,6,22.0,White blood cell count decreased,16744742
3,6,22.0,Stomatitis,16744742
4,6,22.0,Weight decreased,16744742
5,6,22.0,Transaminases increased,16744742
6,6,22.0,Palmar-plantar erythrodysaesthesia syndrome,16744742
7,6,22.0,Anaemia,16744742
8,6,22.0,Nausea,16744742
9,6,22.0,Fatigue,16744742
10,6,22.0,Hypertension,16744742
11,6,22.0,Platelet count decreased,16744742
12,6,22.0,Vomiting,16744742
13,6,22.0,Diarrhoea,16744742
14,6,22.0,Alopecia,16744742
15,6,22.0,Neurotoxicity,16744742
16,6,22.0,Proteinuria,16744742
0,6,22.0,Interstitial lung disease,16744743
1,6,22.0,Hypersensitivity,16744743
0,5,22.0,Death,16744746
0,5,22.0,Death,16744761
0,6,22.0,Blood creatinine increased,16744784
1,6,22.0,Glomerular filtration rate decreased,16744784
0,3,22.1,Rhinorrhoea,16744800
1,6,22.1,Colon cancer,16744800
2,6,22.1,Lacrimation increased,16744800
3,6,22.1,Off label use,16744800
4,6,22.1,Pulmonary thrombosis,16744800
5,6,22.1,Intentional product use issue,16744800
6,6,22.1,Fibromyalgia,16744800
0,,22.1,Acute respiratory failure,16744842
1,,22.1,Tinnitus,16744842
2,,22.1,Product contamination physical,16744842
3,,22.1,Leukocyturia,16744842
4,,22.1,Lung consolidation,16744842
5,,22.1,Recalled product administered,16744842
6,,22.1,Lung opacity,16744842
7,,22.1,Pneumonitis,16744842
8,,22.1,Deafness,16744842
9,,22.1,Cellulitis,16744842
0,2,22.0,Acute kidney injury,16744865
1,2,22.0,Pneumoperitoneum,16744865
2,2,22.0,Pneumatosis intestinalis,16744865
3,6,22.0,Nausea,16744865
4,2,22.0,Gastrointestinal inflammation,16744865
5,1,22.0,Diarrhoea,16744865
6,6,22.0,Intestinal perforation,16744865
0,3,22.0,Hypertension,16744937
1,3,22.0,Glomerulonephritis membranous,16744937
2,3,22.0,Proteinuria,16744937
0,1,22.0,Vomiting,16744955
1,6,22.0,Drug interaction,16744955
2,1,22.0,Febrile neutropenia,16744955
3,1,22.0,Hypokalaemia,16744955
0,6,22.0,Malignant neoplasm progression,16745002
1,6,22.0,Product use in unapproved indication,16745002
2,6,22.0,Tumour pseudoprogression,16745002
0,2,22.0,Dyspnoea,16745024
1,2,22.0,Throat irritation,16745024
0,,22.1,Erythema,16745120
1,,22.1,Infusion related reaction,16745120
2,,22.1,Feeling hot,16745120
3,,22.1,Flushing,16745120
0,6,22.0,No adverse event,16745127
0,5,22.1,Malignant neoplasm progression,16745128
1,3,22.1,Pneumothorax,16745128
0,6,22.0,Pruritus,16745178
1,6,22.0,Fatigue,16745178
2,6,22.0,Haemoglobin decreased,16745178
0,6,22.0,Pain in extremity,16745186
1,6,22.0,Neoplasm progression,16745186
2,6,22.0,Pyrexia,16745186
0,2,22.0,Skin ulcer,16745197
0,5,22.0,Death,16745217
0,6,22.1,Skin disorder,16745256
1,2,22.1,Anxiety,16745256
2,2,22.1,Emotional disorder,16745256
3,2,22.1,Hot flush,16745256
4,6,22.1,Vaginal haemorrhage,16745256
5,6,22.1,Vulvovaginal rash,16745256
6,2,22.1,Nervousness,16745256
7,2,22.1,Tremor,16745256
8,6,22.1,Urinary incontinence,16745256
9,2,22.1,Fatigue,16745256
10,6,22.1,Nausea,16745256
11,2,22.1,Lethargy,16745256
0,6,22.0,Alopecia,16745271
1,6,22.0,Full blood count abnormal,16745271
2,6,22.0,Stomatitis,16745271
3,6,22.0,Nausea,16745271
4,6,22.0,Constipation,16745271
0,3,22.0,Madarosis,16745272
1,3,22.0,Hair texture abnormal,16745272
2,3,22.0,Alopecia,16745272
3,6,22.0,Depression,16745272
4,3,22.0,Hair colour changes,16745272
5,3,22.0,Hair disorder,16745272
0,6,22.1,Memory impairment,16745274
1,6,22.1,Emotional disorder,16745274
2,6,22.1,Migraine,16745274
0,3,22.1,Auditory disorder,16745275
1,6,22.1,Off label use,16745275
2,6,22.1,Abdominal pain upper,16745275
3,6,22.1,Asthenia,16745275
4,6,22.1,Product use in unapproved indication,16745275
0,6,22.1,Blood count abnormal,16745297
1,6,22.1,Fatigue,16745297
2,6,22.1,Anaemia,16745297
0,2,22.1,Blood pressure increased,16745311
0,6,22.0,Neoplasm progression,16745382
0,1,22.0,Pancreatitis,16745389
0,6,22.1,White blood cell count decreased,16745483
0,6,22.0,Neoplasm progression,16745502
0,1,22.0,Diarrhoea,16745541
1,1,22.0,Febrile bone marrow aplasia,16745541
0,6,22.1,Malaise,16745569
1,2,22.1,Flatulence,16745569
2,2,22.1,Dyspepsia,16745569
3,2,22.1,Back pain,16745569
4,6,22.1,Hypertension,16745569
5,6,22.1,Retching,16745569
6,6,22.1,Drug intolerance,16745569
7,6,22.1,Renal cyst,16745569
8,3,22.1,Blood pressure fluctuation,16745569
9,6,22.1,Feeling abnormal,16745569
10,6,22.1,Viral infection,16745569
11,6,22.1,Restlessness,16745569
12,6,22.1,Vomiting,16745569
13,2,22.1,Nausea,16745569
14,2,22.1,Abdominal pain,16745569
15,2,22.1,Headache,16745569
0,5,22.0,Death,16745632
0,1,22.0,Feeling hot,16745665
1,1,22.0,Burning sensation,16745665
2,1,22.0,Sleep disorder,16745665
3,1,22.0,Pain in extremity,16745665
0,1,22.0,Blood pressure increased,16745669
1,1,22.0,Feeling hot,16745669
2,1,22.0,Erythema,16745669
0,6,22.1,Troponin T increased,16745671
1,6,22.1,Myocardial infarction,16745671
0,3,22.0,Asthenia,16745683
1,3,22.0,Fatigue,16745683
2,3,22.0,Off label use,16745683
3,3,22.0,Back pain,16745683
4,3,22.0,Dyspnoea,16745683
5,,22.0,Hospitalisation,16745683
6,3,22.0,Nausea,16745683
7,1,22.0,Pyrexia,16745683
8,3,22.0,Fatigue,16745683
0,6,22.0,Metastases to bone,16745706
0,1,22.0,Epistaxis,16745707
1,6,22.0,Alanine aminotransferase increased,16745707
2,1,22.0,Neutrophil count decreased,16745707
3,6,22.0,Aspartate aminotransferase increased,16745707
4,1,22.0,Mucosal inflammation,16745707
5,1,22.0,Dyspnoea,16745707
6,1,22.0,Nodule,16745707
7,1,22.0,Odynophagia,16745707
8,1,22.0,Neutropenia,16745707
0,6,22.0,Pain,16745719
1,6,22.0,Anxiety,16745719
2,6,22.0,Psychological trauma,16745719
3,6,22.0,Impaired quality of life,16745719
4,2,22.0,Alopecia,16745719
5,6,22.0,Emotional distress,16745719
0,6,22.0,Psychological trauma,16745721
1,2,22.0,Alopecia,16745721
0,3,22.0,Alopecia,16745722
1,6,22.0,Psychological trauma,16745722
0,2,22.1,Alopecia,16745723
1,6,22.1,Psychological trauma,16745723
0,6,22.0,Psychological trauma,16745724
1,3,22.0,Alopecia,16745724
0,2,22.0,Alopecia,16745729
0,2,22.0,Alopecia,16745730
0,2,22.0,Alopecia,16745739
1,6,22.0,Psychological trauma,16745739
0,3,22.0,Alopecia,16745740
1,6,22.0,Psychological trauma,16745740
0,6,22.0,Anxiety,16745748
1,6,22.0,Impaired quality of life,16745748
2,6,22.0,Psychological trauma,16745748
3,6,22.0,Pain,16745748
4,3,22.0,Alopecia,16745748
5,6,22.0,Emotional distress,16745748
6,6,22.0,Discomfort,16745748
0,3,22.1,Alopecia,16745753
1,6,22.1,Anxiety,16745753
2,6,22.1,Emotional distress,16745753
3,6,22.1,Impaired quality of life,16745753
4,6,22.1,Pain,16745753
0,5,22.1,Colitis,16745767
0,6,22.0,Nephropathy,16745769
1,6,22.0,Type 1 diabetes mellitus,16745769
0,2,22.1,Eosinophil count increased,16745770
1,1,22.1,Diarrhoea,16745770
2,1,22.1,Gastroenteritis clostridial,16745770
3,6,22.1,Clostridium test positive,16745770
0,,22.1,Hospitalisation,16745794
0,6,22.0,Chills,16745817
1,1,22.0,Fall,16745817
2,6,22.0,Pyrexia,16745817
3,6,22.0,Muscular weakness,16745817
4,6,22.0,Dyspnoea,16745817
0,5,22.0,Toxicity to various agents,16745850
0,5,22.0,Pneumonia,16745852
1,5,22.0,Febrile neutropenia,16745852
0,1,22.0,Neurotoxicity,16745870
0,4,22.1,Bone marrow failure,16745884
0,1,22.0,Erythema,16745890
1,1,22.0,Feeling hot,16745890
2,1,22.0,Tachycardia,16745890
3,1,22.0,Deep vein thrombosis,16745890
0,,22.1,Alopecia,16745896
0,1,22.0,Flushing,16745901
1,1,22.0,Feeling abnormal,16745901
0,,22.1,Throat tightness,16745922
1,,22.1,Infusion related reaction,16745922
2,,22.1,Chest discomfort,16745922
3,,22.1,Cough,16745922
0,5,22.0,Death,16745942
0,3,22.0,Diarrhoea,16745950
1,6,22.0,Adverse event,16745950
2,3,22.0,Drug intolerance,16745950
0,2,22.0,Eye swelling,16745985
1,2,22.0,Pruritus,16745985
2,3,22.0,Contusion,16745985
0,,22.1,Disease progression,16746071
0,6,22.0,Pyrexia,16746317
1,6,22.0,Systemic inflammatory response syndrome,16746317
2,6,22.0,Product use in unapproved indication,16746317
3,6,22.0,Off label use,16746317
4,6,22.0,Vomiting,16746317
5,6,22.0,Tachycardia,16746317
6,6,22.0,Hypotension,16746317
7,6,22.0,Diarrhoea,16746317
0,6,22.0,Haematotoxicity,16746335
1,6,22.0,Asthenia,16746335
0,5,22.0,Death,16746518
0,5,22.0,Death,16746526
1,1,22.0,Ileus,16746526
2,1,22.0,Incarcerated incisional hernia,16746526
0,1,22.0,Anaphylactic shock,16746527
0,6,22.0,Cardiac dysfunction,16746561
0,6,22.0,Cardiac dysfunction,16746564
0,6,22.0,Cardiac dysfunction,16746565
0,6,22.0,Cardiac dysfunction,16746568
0,6,22.0,Cardiac dysfunction,16746573
0,6,22.0,Cardiac dysfunction,16746581
0,6,22.0,Cardiac dysfunction,16746582
0,2,22.0,Cerebral haemorrhage,16746585
0,1,22.1,Musculoskeletal pain,16746594
1,3,22.1,Pain in extremity,16746594
2,3,22.1,Hypoaesthesia,16746594
3,1,22.1,Skin infection,16746594
4,1,22.1,Sinusitis,16746594
5,1,22.1,Neck pain,16746594
6,5,22.1,Pneumonia,16746594
0,3,22.0,Vertigo,16746618
0,6,22.0,Oesophageal carcinoma,16746628
1,6,22.0,Dementia,16746628
2,6,22.0,Dysphagia,16746628
3,5,22.0,Death,16746628
4,6,22.0,Breast cancer,16746628
0,6,22.0,Cardiac dysfunction,16746647
0,3,22.0,Osteonecrosis of jaw,16746681
0,1,22.1,Vomiting,16746690
1,1,22.1,Nausea,16746690
0,1,22.0,Flushing,16746717
1,1,22.0,Feeling abnormal,16746717
0,2,22.0,Bone marrow failure,16746735
0,2,22.0,Alopecia,16746764
1,6,22.0,Psychological trauma,16746764
0,2,22.0,Alopecia,16746772
1,6,22.0,Psychological trauma,16746772
0,2,22.0,Alopecia,16746774
1,6,22.0,Psychological trauma,16746774
0,6,22.1,Psychological trauma,16746777
1,2,22.1,Alopecia,16746777
0,2,22.0,Alopecia,16746780
0,6,22.0,Pneumonia,16746786
1,6,22.0,Product dose omission,16746786
0,3,22.0,Alopecia,16746790
1,6,22.0,Psychological trauma,16746790
0,6,22.1,Impaired quality of life,16746800
1,6,22.1,Anxiety,16746800
2,2,22.1,Alopecia,16746800
3,6,22.1,Emotional distress,16746800
4,6,22.1,Pain,16746800
0,6,22.0,Prostate cancer,16746834
1,1,22.0,Coronary artery occlusion,16746834
2,6,22.0,Drug interaction,16746834
0,6,22.1,Type 1 diabetes mellitus,16746852
1,6,22.1,Full blood count increased,16746852
2,6,22.1,Blood pressure decreased,16746852
3,6,22.1,Malaise,16746852
4,6,22.1,Fall,16746852
5,6,22.1,Hip fracture,16746852
6,1,22.1,Hepatic infection,16746852
7,6,22.1,Rhinorrhoea,16746852
8,6,22.1,Intentional dose omission,16746852
0,1,22.0,Dyspnoea,16746859
1,1,22.0,Chest pain,16746859
2,1,22.0,Hypertensive crisis,16746859
3,1,22.0,Vomiting,16746859
0,1,22.0,Bone marrow failure,16746867
0,6,22.1,Haemoglobin decreased,16746870
1,6,22.1,Gastrointestinal haemorrhage,16746870
2,6,22.1,Gastric ulcer,16746870
3,1,22.1,Product use complaint,16746870
4,6,22.1,Anaemia,16746870
5,1,22.1,Foreign body in respiratory tract,16746870
0,6,22.0,Hepatic steatosis,16746924
0,6,22.0,Colitis,16747010
0,2,22.1,Radiation pneumonitis,16747022
1,2,22.1,Venous thrombosis limb,16747022
2,6,22.1,Tuberculous pleurisy,16747022
3,1,22.1,Herpes zoster,16747022
4,6,22.1,Pulmonary tuberculosis,16747022
5,1,22.1,Pneumothorax,16747022
0,3,22.0,Migraine with aura,16747190
0,1,22.0,Acute kidney injury,16747219
1,6,22.0,Decreased appetite,16747219
0,5,22.0,Death,16747246
0,6,22.0,Osteopenia,16747248
1,3,22.0,Ankle fracture,16747248
2,1,22.0,Herpes zoster,16747248
3,6,22.0,Urinary tract infection,16747248
4,6,22.0,Joint swelling,16747248
5,6,22.0,Chest wall mass,16747248
6,3,22.0,Osteoporosis,16747248
0,6,22.0,Metastases to central nervous system,16747249
0,6,22.0,Product use in unapproved indication,16747307
1,5,22.0,Death,16747307
0,5,22.0,Death,16747348
0,3,22.0,Dyspnoea,16747358
1,3,22.0,Left ventricular failure,16747358
2,3,22.0,Oedema,16747358
3,6,22.0,Constipation,16747358
0,3,22.1,Genital injury,16747391
1,1,22.1,Rash,16747391
2,3,22.1,Pruritus,16747391
3,1,22.1,Hypoxia,16747391
4,3,22.1,Skin laceration,16747391
0,5,22.0,Small cell lung cancer,16747397
0,1,22.0,Pneumonitis,16747399
1,1,22.0,Device failure,16747399
2,1,22.0,Chlamydial infection,16747399
0,6,22.0,Performance status decreased,16747435
1,5,22.0,Malignant neoplasm progression,16747435
0,5,22.0,Sepsis,16747441
1,5,22.0,Condition aggravated,16747441
2,6,22.0,Malignant neoplasm progression,16747441
3,5,22.0,Dyspnoea,16747441
0,1,22.1,Secondary adrenocortical insufficiency,16747450
0,6,22.0,Osteonecrosis of jaw,16747473
0,,22.0,Diarrhoea,16747486
1,,22.0,Hepatic function abnormal,16747486
2,,22.0,Off label use,16747486
3,3,22.0,Bone marrow failure,16747486
0,1,22.0,Erysipelas,16747492
0,3,22.0,Maculopathy,16747511
1,3,22.0,Visual acuity reduced,16747511
0,5,22.1,Myositis,16747537
1,6,22.1,Metastases to lymph nodes,16747537
2,6,22.1,Myocarditis,16747537
3,6,22.1,Restlessness,16747537
4,6,22.1,Metastases to liver,16747537
5,6,22.1,Delirium,16747537
6,6,22.1,Dizziness postural,16747537
7,6,22.1,Vertigo,16747537
8,6,22.1,Eyelid ptosis,16747537
9,6,22.1,Asthenia,16747537
10,6,22.1,Tinnitus,16747537
11,6,22.1,Myasthenia gravis,16747537
12,6,22.1,Pneumonia,16747537
13,6,22.1,Blood creatine phosphokinase increased,16747537
0,1,22.0,Agranulocytosis,16747554
1,6,22.0,Drug interaction,16747554
2,1,22.0,Clostridium difficile colitis,16747554
0,6,22.0,Blood cholesterol increased,16747557
1,3,22.0,Aphasia,16747557
2,6,22.0,Transient ischaemic attack,16747557
3,1,22.0,Blood pressure increased,16747557
4,3,22.0,Paraesthesia,16747557
5,3,22.0,Thrombosis,16747557
0,6,22.1,General physical health deterioration,16747576
1,5,22.1,Death,16747576
2,6,22.1,Diabetes mellitus,16747576
3,6,22.1,Cushing^s syndrome,16747576
0,5,22.1,Prostate cancer,16747580
1,6,22.1,Drug ineffective,16747580
0,3,22.0,Renal failure,16747583
1,3,22.0,Hepatic failure,16747583
0,3,22.0,Hepatitis toxic,16747625
0,6,22.0,Oedema,16747627
1,6,22.0,Asthenia,16747627
2,6,22.0,Dyspnoea,16747627
3,6,22.0,Fatigue,16747627
4,6,22.0,Pain,16747627
0,5,22.0,Second primary malignancy,16747640
1,5,22.0,Acute myeloid leukaemia,16747640
0,1,22.1,Decreased appetite,16747667
1,2,22.1,Tubulointerstitial nephritis,16747667
0,3,22.0,Neuropathy peripheral,16747668
1,3,22.0,Neuropathy peripheral,16747668
2,3,22.0,Trigger finger,16747668
0,6,22.1,Bronchial obstruction,16747678
1,5,22.1,Cardiac arrest,16747678
2,2,22.1,Radiation pneumonitis,16747678
3,5,22.1,Septic shock,16747678
4,2,22.1,Pneumonia bacterial,16747678
5,5,22.1,Urinary tract infection,16747678
0,6,22.0,Drug ineffective,16747679
1,6,22.0,Malignant neoplasm progression,16747679
2,6,22.0,Carbohydrate antigen 125 increased,16747679
0,1,22.1,Interstitial lung disease,16747683
0,3,22.0,Metastases to bone,16747685
1,3,22.0,Metastases to skin,16747685
2,3,22.0,Metastases to lung,16747685
3,3,22.0,Metastases to lymph nodes,16747685
0,2,22.1,Pneumonitis,16747689
1,2,22.1,Skin disorder,16747689
0,3,22.1,Renal failure,16747695
1,6,22.1,Eastern Cooperative Oncology Group performance status worsened,16747695
2,6,22.1,Thrombocytopenia,16747695
3,2,22.1,Anaemia,16747695
0,3,22.1,Hair colour changes,16747718
1,3,22.1,Madarosis,16747718
2,3,22.1,Alopecia,16747718
3,3,22.1,Hair disorder,16747718
4,3,22.1,Hair texture abnormal,16747718
0,3,22.1,Hair disorder,16747731
1,3,22.1,Hair texture abnormal,16747731
2,3,22.1,Alopecia,16747731
3,3,22.1,Madarosis,16747731
4,3,22.1,Hair colour changes,16747731
0,6,22.0,Anxiety,16747732
1,3,22.0,Alopecia,16747732
2,3,22.0,Madarosis,16747732
3,3,22.0,Hair texture abnormal,16747732
4,3,22.0,Hair colour changes,16747732
5,3,22.0,Hair disorder,16747732
0,3,22.0,Tinnitus,16747738
0,1,22.0,Lacrimation increased,16747758
1,1,22.0,Dacryostenosis acquired,16747758
2,1,22.0,Dermatitis,16747758
3,6,22.0,Product use in unapproved indication,16747758
0,3,22.0,Taste disorder,16747833
1,6,22.0,Malignant neoplasm progression,16747833
2,1,22.0,Pneumonia,16747833
3,1,22.0,Headache,16747833
4,1,22.0,Nausea,16747833
5,1,22.0,Pyrexia,16747833
6,1,22.0,Diarrhoea,16747833
7,6,22.0,Breast cancer,16747833
8,1,22.0,Pyrexia,16747833
9,1,22.0,Abdominal rigidity,16747833
10,1,22.0,Cough,16747833
11,3,22.0,Weight decreased,16747833
12,1,22.0,Nasopharyngitis,16747833
13,3,22.0,Fatigue,16747833
14,3,22.0,Decreased appetite,16747833
15,3,22.0,Diarrhoea,16747833
16,2,22.0,Vaginal haemorrhage,16747833
0,3,22.0,Osteonecrosis of jaw,16747858
0,2,22.0,Cor pulmonale acute,16747879
1,2,22.0,Pulmonary embolism,16747879
2,2,22.0,Cardiorenal syndrome,16747879
0,6,22.0,Rash,16747924
1,6,22.0,Diarrhoea,16747924
2,6,22.0,Acne,16747924
0,1,22.0,Palmar-plantar erythrodysaesthesia syndrome,16747955
1,6,22.0,Neuropathy peripheral,16747955
2,1,22.0,Metastases to peritoneum,16747955
3,1,22.0,Seborrhoea,16747955
0,6,22.0,Neuropathy peripheral,16748016
1,6,22.0,Product use in unapproved indication,16748016
0,1,22.0,Anaphylactic shock,16748066
0,1,22.0,Adrenal insufficiency,16748085
1,3,22.0,Deafness unilateral,16748085
2,3,22.0,Dizziness,16748085
0,6,22.0,Mucosal inflammation,16748117
1,6,22.0,Hypertension,16748117
2,5,22.0,Death,16748117
3,6,22.0,Alanine aminotransferase increased,16748117
4,6,22.0,Palmar-plantar erythrodysaesthesia syndrome,16748117
5,6,22.0,Aspartate aminotransferase increased,16748117
6,6,22.0,Weight increased,16748117
7,6,22.0,Malaise,16748117
0,3,22.0,Rash,16748127
1,3,22.0,Dry mouth,16748127
2,3,22.0,Oral pruritus,16748127
3,3,22.0,Skin exfoliation,16748127
4,3,22.0,Nasal dryness,16748127
5,6,22.0,Product use in unapproved indication,16748127
6,3,22.0,Nasal pruritus,16748127
0,3,22.0,Fatigue,16748205
1,3,22.0,Metastases to lung,16748205
2,3,22.0,Proctalgia,16748205
3,3,22.0,Asthenia,16748205
0,3,22.0,Fatigue,16748261
1,6,22.0,Haemoglobin decreased,16748261
0,6,22.1,Haematoma,16748271
1,6,22.1,Road traffic accident,16748271
2,2,22.1,Papillary thyroid cancer,16748271
3,6,22.1,Accident,16748271
4,6,22.1,Eye haemorrhage,16748271
0,6,22.0,Cardiac dysfunction,16748277
0,6,22.0,Cardiac dysfunction,16748278
0,6,22.0,Cardiac dysfunction,16748279
0,6,22.0,Cardiac dysfunction,16748282
0,1,22.0,Fall,16748342
0,3,22.0,Treatment failure,16748407
0,6,22.0,Disease progression,16748412
0,6,22.0,Metastases to central nervous system,16748472
1,6,22.0,Intentional product use issue,16748472
2,6,22.0,Off label use,16748472
0,2,22.0,Anaemia,16748557
1,2,22.0,Gastric ulcer,16748557
2,2,22.0,Gastrooesophageal reflux disease,16748557
0,6,22.0,Intestinal obstruction,16748559
0,1,22.0,Neutropenia,16748610
0,1,22.0,Stomatitis,16748611
1,3,22.0,Pain,16748611
2,1,22.0,Pancytopenia,16748611
0,2,22.0,Enterobacter infection,16748628
1,6,22.0,Septic shock,16748628
2,2,22.0,Bacterial translocation,16748628
3,2,22.0,Bacteraemia,16748628
0,3,22.0,Metastatic neoplasm,16748665
1,6,22.0,Hydronephrosis,16748665
2,3,22.0,Ill-defined disorder,16748665
3,3,22.0,Metastasis,16748665
0,5,22.1,Foetal exposure during pregnancy,16748715
1,5,22.1,Foetal death,16748715
2,5,22.1,Stillbirth,16748715
3,5,22.1,Neonatal asphyxia,16748715
0,5,22.0,Pleural effusion,16748758
1,5,22.0,Respiratory failure,16748758
2,5,22.0,Nodule,16748758
3,5,22.0,Lung disorder,16748758
4,5,22.0,Anxiety,16748758
5,5,22.0,Condition aggravated,16748758
6,5,22.0,Restlessness,16748758
7,5,22.0,Neoplasm malignant,16748758
8,5,22.0,Pericardial effusion,16748758
0,1,22.0,Large intestinal haemorrhage,16748782
1,6,22.0,Adverse drug reaction,16748782
2,3,22.0,Blood pressure increased,16748782
0,1,22.1,Hepatic function abnormal,16748784
1,2,22.1,Liver injury,16748784
0,1,22.0,Bladder cancer recurrent,16748790
1,6,22.0,Urethritis noninfective,16748790
2,6,22.0,Discomfort,16748790
3,6,22.0,Inappropriate schedule of product administration,16748790
4,6,22.0,Product availability issue,16748790
5,6,22.0,Product dose omission,16748790
0,3,22.1,Dyspepsia,16748809
1,6,22.1,Therapeutic product effect decreased,16748809
2,6,22.1,Drug interaction,16748809
3,1,22.1,Fatigue,16748809
4,3,22.1,Abdominal discomfort,16748809
5,1,22.1,Myalgia,16748809
6,1,22.1,Arthralgia,16748809
7,6,22.1,Intentional product use issue,16748809
0,1,22.1,Blood calcium decreased,16748836
1,2,22.1,Liver function test increased,16748836
2,1,22.1,Pleural effusion,16748836
0,1,22.0,Disease progression,16748853
1,6,22.0,Drug ineffective,16748853
0,5,22.0,Gastrointestinal perforation,16748898
1,5,22.0,Drug interaction,16748898
0,3,22.0,Cholestasis,16748910
1,3,22.0,Hepatocellular injury,16748910
0,5,22.0,Death,16748918
0,1,22.0,Hepatitis cholestatic,16749000
0,1,22.1,Pyrexia,16749070
1,1,22.1,Interstitial lung disease,16749070
2,1,22.1,Weight decreased,16749070
3,1,22.1,Malaise,16749070
0,6,22.0,Cognitive disorder,16749093
1,6,22.0,Acalculia,16749093
2,5,22.0,Malignant neoplasm progression,16749093
0,3,22.1,Testicular atrophy,16749097
1,3,22.1,Weight increased,16749097
2,3,22.1,Back pain,16749097
3,3,22.1,Peripheral swelling,16749097
4,3,22.1,Pruritus,16749097
5,6,22.1,Rash,16749097
6,3,22.1,Hypoaesthesia,16749097
7,3,22.1,Muscle spasms,16749097
8,3,22.1,Disturbance in sexual arousal,16749097
9,3,22.1,Macule,16749097
10,3,22.1,Feeling hot,16749097
0,6,22.0,Oropharyngeal pain,16749110
1,6,22.0,Skin discolouration,16749110
2,6,22.0,Hair colour changes,16749110
0,1,22.1,Urosepsis,16749134
1,1,22.1,Urinary tract infection,16749134
2,1,22.1,Ileus,16749134
3,1,22.1,Pneumonia,16749134
4,6,22.1,Product use in unapproved indication,16749134
0,1,22.0,Orthostatic hypotension,16749153
0,5,22.0,Prostate cancer,16749162
0,3,22.0,Chills,16749195
1,3,22.0,Femur fracture,16749195
2,3,22.0,Aspartate aminotransferase increased,16749195
3,3,22.0,Arthropathy,16749195
4,3,22.0,Gamma-glutamyltransferase increased,16749195
5,3,22.0,Malignant neoplasm progression,16749195
6,3,22.0,Paraesthesia,16749195
7,3,22.0,Nausea,16749195
8,3,22.0,Blood pressure diastolic decreased,16749195
9,3,22.0,Pain in extremity,16749195
10,3,22.0,Blood albumin decreased,16749195
11,3,22.0,Blood alkaline phosphatase increased,16749195
12,3,22.0,Blood lactate dehydrogenase increased,16749195
13,3,22.0,Headache,16749195
14,3,22.0,Scintillating scotoma,16749195
15,3,22.0,Haemoglobin decreased,16749195
16,3,22.0,Insomnia,16749195
17,3,22.0,Lymphocyte count decreased,16749195
18,3,22.0,Red blood cell count decreased,16749195
19,3,22.0,Cerebrovascular accident,16749195
20,3,22.0,Osteoporosis,16749195
21,3,22.0,Body temperature decreased,16749195
22,3,22.0,Mean cell haemoglobin concentration decreased,16749195
23,3,22.0,Blood glucose decreased,16749195
24,6,22.0,Product use in unapproved indication,16749195
0,3,22.1,Pain,16749206
1,3,22.1,Pain,16749206
2,2,22.1,Immune thrombocytopenic purpura,16749206
3,3,22.1,Chest discomfort,16749206
0,6,22.1,Malignant neoplasm progression,16749246
1,5,22.1,Cerebral infarction,16749246
2,5,22.1,Cerebrovascular accident,16749246
0,6,22.0,Vasculitic rash,16749317
1,6,22.0,Sjogren^s syndrome,16749317
2,2,22.0,Dry eye,16749317
0,6,22.0,Menopause,16749320
1,6,22.0,Deafness,16749320
0,5,22.0,Lung infection,16749338
0,2,22.0,Atelectasis,16749351
0,6,22.0,Feeling hot,16749419
1,2,22.0,Headache,16749419
2,6,22.0,Tumour marker increased,16749419
3,6,22.0,Chills,16749419
4,6,22.0,Nausea,16749419
5,6,22.0,Fatigue,16749419
6,6,22.0,Full blood count decreased,16749419
7,6,22.0,Pyrexia,16749419
8,6,22.0,Neuropathy peripheral,16749419
9,6,22.0,Asthenia,16749419
10,6,22.0,White blood cell count decreased,16749419
11,6,22.0,Mental disorder,16749419
12,6,22.0,Fall,16749419
0,5,22.0,Performance status decreased,16749455
1,6,22.0,Intentional product use issue,16749455
2,6,22.0,Leukopenia,16749455
3,6,22.0,Diarrhoea,16749455
4,5,22.0,Off label use,16749455
0,2,22.0,Paraesthesia,16749463
1,2,22.0,Arthralgia,16749463
2,2,22.0,Asthenia,16749463
3,2,22.0,Pancytopenia,16749463
0,6,22.0,Thrombosis,16749505
1,6,22.0,Erythema,16749505
2,6,22.0,Weight increased,16749505
3,6,22.0,Pain,16749505
0,6,22.0,Gastrointestinal disorder,16749510
1,6,22.0,Cough,16749510
2,6,22.0,Fatigue,16749510
3,6,22.0,Pyrexia,16749510
4,6,22.0,Hypoxia,16749510
5,6,22.0,Atelectasis,16749510
6,6,22.0,Nausea,16749510
7,6,22.0,Computerised tomogram thorax abnormal,16749510
8,6,22.0,Off label use,16749510
9,6,22.0,Dyspnoea,16749510
10,6,22.0,Rash,16749510
0,5,22.0,Pneumonia,16749595
1,5,22.0,Full blood count,16749595
2,5,22.0,Febrile neutropenia,16749595
0,6,22.0,Liver disorder,16749615
1,6,22.0,Decreased appetite,16749615
2,6,22.0,Abdominal distension,16749615
3,6,22.0,Diarrhoea,16749615
4,6,22.0,Gait disturbance,16749615
5,6,22.0,Bone pain,16749615
6,6,22.0,Neoplasm progression,16749615
7,6,22.0,Feeling abnormal,16749615
0,1,22.0,Anaemia,16749638
1,1,22.0,Nausea,16749638
2,3,22.0,Peripheral sensory neuropathy,16749638
3,1,22.0,Vomiting,16749638
4,6,22.0,Product use issue,16749638
5,1,22.0,Fatigue,16749638
0,3,22.0,Dehydration,16749664
1,3,22.0,Dyspnoea exertional,16749664
2,3,22.0,Vomiting,16749664
3,3,22.0,Nausea,16749664
4,3,22.0,Oesophageal varices haemorrhage,16749664
5,3,22.0,Diarrhoea,16749664
6,3,22.0,Insomnia,16749664
0,3,22.0,Coronary artery occlusion,16749714
1,3,22.0,Dyspnoea exertional,16749714
2,3,22.0,Gastric ulcer haemorrhage,16749714
3,3,22.0,Injection site pain,16749714
4,3,22.0,Weight increased,16749714
5,3,22.0,Dysstasia,16749714
6,3,22.0,Oedema,16749714
7,3,22.0,Hot flush,16749714
8,3,22.0,Weight decreased,16749714
9,3,22.0,Myocardial infarction,16749714
10,1,22.0,Burning sensation,16749714
11,3,22.0,Fatigue,16749714
12,1,22.0,Myalgia,16749714
13,2,22.0,Injection site nodule,16749714
14,3,22.0,Constipation,16749714
15,3,22.0,Incorrect drug administration rate,16749714
16,3,22.0,Nocturia,16749714
17,2,22.0,Injection site swelling,16749714
18,3,22.0,Vertigo,16749714
0,1,22.1,Myocardial infarction,16749728
0,6,22.1,Cardiac disorder,16749750
1,3,22.1,Blood creatinine increased,16749750
2,6,22.1,Blood pressure abnormal,16749750
3,6,22.1,Haemorrhage subcutaneous,16749750
4,3,22.1,Contusion,16749750
5,1,22.1,Blood potassium increased,16749750
6,3,22.1,Thrombocytopenia,16749750
7,2,22.1,Blood urea increased,16749750
8,3,22.1,Haematocrit decreased,16749750
9,6,22.1,Renal disorder,16749750
10,6,22.1,Inappropriate schedule of product administration,16749750
11,1,22.1,Skin discolouration,16749750
12,3,22.1,Haemoglobin decreased,16749750
13,6,22.1,Expired product administered,16749750
0,1,22.0,Leukopenia,16749761
1,1,22.0,Febrile neutropenia,16749761
2,1,22.0,Escherichia sepsis,16749761
3,1,22.0,Large intestine infection,16749761
0,3,22.0,Adverse event,16749795
1,3,22.0,Drug ineffective for unapproved indication,16749795
0,6,22.0,Nerve injury,16749802
1,6,22.0,Dehydration,16749802
2,6,22.0,General physical health deterioration,16749802
3,6,22.0,Atrial fibrillation,16749802
4,6,22.0,Heart rate increased,16749802
5,6,22.0,Decreased appetite,16749802
6,3,22.0,Back pain,16749802
0,3,22.0,Hyperaesthesia,16749805
1,6,22.0,Gait inability,16749805
2,3,22.0,Balance disorder,16749805
3,3,22.0,Neuropathy peripheral,16749805
4,6,22.0,White blood cell count increased,16749805
0,6,22.0,Back pain,16749809
1,6,22.0,Dysphonia,16749809
2,6,22.0,Appetite disorder,16749809
3,6,22.0,Groin pain,16749809
4,6,22.0,Pain,16749809
5,6,22.0,Skin lesion,16749809
6,6,22.0,Paraesthesia,16749809
7,6,22.0,Back injury,16749809
8,1,22.0,Cough,16749809
9,6,22.0,Nausea,16749809
10,6,22.0,Bone lesion,16749809
11,2,22.0,Hypokinesia,16749809
12,2,22.0,Pain in extremity,16749809
13,6,22.0,Insomnia,16749809
14,6,22.0,Dysgeusia,16749809
15,6,22.0,Metastases to bone,16749809
16,6,22.0,Full blood count decreased,16749809
0,6,22.0,Oestrogen receptor positive breast cancer,16749816
1,6,22.0,Malignant neoplasm progression,16749816
2,6,22.0,Dyspnoea,16749816
3,6,22.0,Pleural effusion,16749816
0,6,22.0,Abdominal distension,16749818
1,6,22.0,Mucosal haemorrhage,16749818
2,6,22.0,Pruritus,16749818
3,6,22.0,Vomiting,16749818
4,6,22.0,Diarrhoea,16749818
5,6,22.0,Saliva discolouration,16749818
6,6,22.0,Loss of consciousness,16749818
7,6,22.0,Hypoaesthesia,16749818
8,6,22.0,Syncope,16749818
9,6,22.0,Sinus bradycardia,16749818
0,6,22.1,Rectal cancer,16749819
1,6,22.1,Second primary malignancy,16749819
2,6,22.1,Ileus paralytic,16749819
0,3,22.0,Breast cancer,16749823
1,6,22.0,Bone marrow infiltration,16749823
2,6,22.0,Metastases to bone,16749823
3,3,22.0,Malignant neoplasm progression,16749823
4,6,22.0,Pain,16749823
5,6,22.0,Drug intolerance,16749823
6,6,22.0,Drug ineffective,16749823
0,1,22.0,Hypercalcaemia,16749828
0,6,22.0,Wrong technique in product usage process,16749830
1,6,22.0,Atrial fibrillation,16749830
0,1,22.0,Bradycardia,16749852
1,1,22.0,Electrocardiogram QT prolonged,16749852
0,6,22.0,Breast cancer,16749854
1,6,22.0,Blood pressure decreased,16749854
2,6,22.0,Drug ineffective,16749854
3,6,22.0,Decreased appetite,16749854
4,6,22.0,Diarrhoea,16749854
5,6,22.0,Decreased immune responsiveness,16749854
6,6,22.0,Depressed mood,16749854
7,6,22.0,Vomiting,16749854
8,6,22.0,Weight decreased,16749854
9,6,22.0,Malignant neoplasm progression,16749854
10,6,22.0,Discomfort,16749854
11,6,22.0,Feeling of despair,16749854
0,6,22.0,Dermatomyositis,16749868
0,1,22.0,Tachycardia,16749873
1,1,22.0,Malaise,16749873
2,1,22.0,Bronchospasm,16749873
3,1,22.0,Hypersensitivity,16749873
4,1,22.0,Hyperhidrosis,16749873
0,1,22.0,Rash pruritic,16749893
1,1,22.0,Rash erythematous,16749893
2,1,22.0,Pain,16749893
0,,22.1,Death,16749900
0,3,22.0,Bundle branch block left,16749902
1,3,22.0,Neutropenia,16749902
0,6,22.1,Decreased appetite,16749922
1,1,22.1,Hepatotoxicity,16749922
2,6,22.1,Pruritus,16749922
0,1,22.0,Hypokalaemia,16749944
1,1,22.0,Febrile neutropenia,16749944
2,1,22.0,Vomiting,16749944
0,1,22.0,Embolic stroke,16749952
1,1,22.0,Thrombocytopenia,16749952
2,1,22.0,Ventricular hypokinesia,16749952
3,1,22.0,Hypomagnesaemia,16749952
4,1,22.0,Ischaemic stroke,16749952
5,1,22.0,Cardiac ventricular thrombosis,16749952
0,,22.1,Therapy cessation,16749969
1,,22.1,Hospitalisation,16749969
0,6,22.0,Pain,16750039
0,6,22.0,Prostatic specific antigen increased,16750057
1,6,22.0,Blood alkaline phosphatase increased,16750057
2,6,22.0,Pain,16750057
0,6,22.0,Prostatic specific antigen increased,16750067
1,6,22.0,Pain,16750067
0,6,22.0,Pain,16750071
1,6,22.0,Prostatic specific antigen increased,16750071
0,,22.1,Product administration error,16750124
1,,22.1,Inappropriate schedule of product administration,16750124
0,3,22.1,Pain,16750165
1,3,22.1,Gait disturbance,16750165
0,,22.1,Death,16750177
0,6,22.0,Fatigue,16750191
1,6,22.0,Lymphoedema,16750191
2,2,22.0,Tumour marker increased,16750191
3,6,22.0,Asthenia,16750191
4,6,22.0,Malaise,16750191
0,6,22.1,Nausea,16750198
1,3,22.1,White blood cell count decreased,16750198
2,6,22.1,Neoplasm progression,16750198
3,2,22.1,Pneumonia,16750198
4,6,22.1,Blood count abnormal,16750198
0,6,22.0,Malaise,16750201
1,6,22.0,Eating disorder,16750201
2,6,22.0,Neoplasm progression,16750201
3,6,22.0,Vomiting,16750201
0,6,22.0,Blood urea increased,16750208
1,6,22.0,Blood creatinine increased,16750208
0,6,22.0,Neoplasm progression,16750212
0,6,22.0,Thyroid mass,16750213
0,2,22.0,Hepatic function abnormal,16750218
0,6,22.0,Discomfort,16750227
0,6,22.0,Pulmonary valve incompetence,16750228
1,2,22.0,Asthenia,16750228
2,6,22.0,Mitral valve incompetence,16750228
3,2,22.0,Yellow skin,16750228
4,2,22.0,Hepatotoxicity,16750228
5,2,22.0,Nausea,16750228
6,2,22.0,Vomiting,16750228
7,6,22.0,Pericardial effusion,16750228
8,2,22.0,Hyperbilirubinaemia,16750228
9,6,22.0,Pulmonary hypertension,16750228
10,6,22.0,Dilatation atrial,16750228
11,6,22.0,Tricuspid valve incompetence,16750228
0,6,22.0,Rash,16750231
1,6,22.0,Exfoliative rash,16750231
2,6,22.0,Rash papular,16750231
0,6,22.0,Acute kidney injury,16750287
1,6,22.0,Neoplasm progression,16750287
2,6,22.0,Anaemia,16750287
0,1,22.0,Deep vein thrombosis,16750291
0,6,22.0,Malignant neoplasm progression,16750311
0,6,22.0,Dysphagia,16750327
1,1,22.0,Drug hypersensitivity,16750327
2,6,22.0,Intestinal obstruction,16750327
0,6,22.0,Full blood count abnormal,16750328
0,6,22.1,Blood count abnormal,16750347
0,2,22.0,Pancreatitis acute,16750374
0,1,22.0,Pneumatosis intestinalis,16750391
0,6,22.1,Off label use,16750449
1,6,22.1,Cystitis,16750449
2,6,22.1,Neoplasm progression,16750449
3,6,22.1,Product use in unapproved indication,16750449
0,6,22.1,Decreased appetite,16750462
1,6,22.1,Nausea,16750462
2,6,22.1,Taste disorder,16750462
3,6,22.1,Insomnia,16750462
4,6,22.1,Dyspnoea,16750462
5,6,22.1,Musculoskeletal chest pain,16750462
6,6,22.1,Dizziness,16750462
7,6,22.1,Balance disorder,16750462
0,3,22.1,Red blood cell count decreased,16750484
1,2,22.1,Malaise,16750484
2,2,22.1,Haematocrit decreased,16750484
3,2,22.1,Asthenia,16750484
4,3,22.1,White blood cell count decreased,16750484
5,2,22.1,Dizziness,16750484
6,2,22.1,Cystitis,16750484
7,2,22.1,Gait disturbance,16750484
8,1,22.1,Tonsillitis,16750484
9,1,22.1,Thrombocytopenia,16750484
10,1,22.1,Urinary tract infection,16750484
11,3,22.1,Neutropenia,16750484
0,6,22.0,Hyperhidrosis,16750492
1,6,22.0,Breast haemorrhage,16750492
0,5,22.0,Death,16750499
0,6,22.0,Alopecia,16750533
0,1,22.1,Myositis,16750541
1,4,22.1,Myocarditis,16750541
0,6,22.1,Malaise,16750562
0,5,22.0,Death,16750596
0,6,22.1,Malaise,16750599
1,6,22.1,Dehydration,16750599
2,1,22.1,Vomiting,16750599
0,5,22.0,Death,16750697
0,5,22.0,Death,16750700
0,6,22.0,Headache,16750784
0,1,22.1,Atrioventricular block,16750794
1,3,22.1,Proteinuria,16750794
2,3,22.1,Pleural effusion,16750794
3,2,22.1,Hypertension,16750794
0,3,22.0,Respiratory failure,16750805
1,3,22.0,Obstructive airways disorder,16750805
2,3,22.0,Mucosal toxicity,16750805
0,3,22.0,Cataract,16750829
1,3,22.0,Sleep disorder,16750829
2,3,22.0,Hot flush,16750829
3,3,22.0,Hyperhidrosis,16750829
4,3,22.0,Fatigue,16750829
0,3,22.0,Vomiting,16750878
1,1,22.0,Anaemia,16750878
2,3,22.0,Back pain,16750878
3,1,22.0,Hypocalcaemia,16750878
4,1,22.0,Anaemia,16750878
5,1,22.0,White blood cell count decreased,16750878
6,1,22.0,Neutropenia,16750878
7,1,22.0,White blood cell count decreased,16750878
8,1,22.0,Hypophosphataemia,16750878
9,3,22.0,Arthralgia,16750878
10,1,22.0,Neutropenia,16750878
11,1,22.0,White blood cell count decreased,16750878
12,1,22.0,Musculoskeletal chest pain,16750878
13,1,22.0,Visual impairment,16750878
14,1,22.0,Arthralgia,16750878
15,3,22.0,White blood cell count decreased,16750878
16,1,22.0,Hypocalcaemia,16750878
17,1,22.0,Rash,16750878
18,1,22.0,Thrombocytopenia,16750878
19,3,22.0,Nausea,16750878
20,1,22.0,Hypocalcaemia,16750878
21,1,22.0,Neutropenia,16750878
22,1,22.0,Hypomagnesaemia,16750878
23,4,22.0,Diarrhoea,16750878
24,1,22.0,Back pain,16750878
25,1,22.0,Neutropenia,16750878
26,3,22.0,Neutropenia,16750878
27,1,22.0,Anaemia,16750878
28,1,22.0,Hypophosphataemia,16750878
0,6,22.0,Drug interaction,16750902
1,1,22.0,Orthostatic hypotension,16750902
2,1,22.0,Condition aggravated,16750902
3,1,22.0,Malaise,16750902
0,1,22.0,Daydreaming,16750938
0,6,22.0,Lymphatic disorder,16750939
1,6,22.0,Respiratory disorder,16750939
2,6,22.0,Blood disorder,16750939
3,6,22.0,Asthenia,16750939
4,6,22.0,Fatigue,16750939
5,6,22.0,Gastrointestinal disorder,16750939
0,6,22.0,Left atrial enlargement,16750945
1,6,22.0,Electrocardiogram QRS complex prolonged,16750945
2,6,22.0,Myocardial infarction,16750945
0,5,22.1,Malignant neoplasm progression,16750959
1,1,22.1,Renal disorder,16750959
2,1,22.1,Liver disorder,16750959
0,6,22.0,Malignant neoplasm progression,16750960
1,6,22.0,Drug resistance,16750960
0,2,22.0,Laryngeal oedema,16750966
1,2,22.0,Dyspnoea,16750966
2,6,22.0,Urinary tract infection,16750966
3,2,22.0,Oedema mouth,16750966
0,3,22.0,Gastrointestinal disorder,16751030
1,6,22.0,Ingrowing nail,16751030
2,6,22.0,Central nervous system lesion,16751030
3,3,22.0,Epistaxis,16751030
4,6,22.0,Ulcer,16751030
5,3,22.0,Mouth ulceration,16751030
6,3,22.0,Limb injury,16751030
7,6,22.0,Nasal ulcer,16751030
8,6,22.0,Diarrhoea,16751030
0,6,22.0,Pyrexia,16751039
1,6,22.0,Pneumonia,16751039
0,6,22.0,Leukaemia,16751054
0,1,22.0,Dyspnoea,16751057
1,1,22.0,Hot flush,16751057
2,1,22.0,Oxygen saturation decreased,16751057
3,1,22.0,Dysphagia,16751057
4,1,22.0,Nausea,16751057
5,1,22.0,Somnolence,16751057
0,6,22.0,White blood cell count decreased,16751077
1,1,22.0,Neutropenia,16751077
0,1,22.1,Chills,16751079
0,1,22.0,Aspartate aminotransferase increased,16751106
1,1,22.0,Alanine aminotransferase increased,16751106
2,1,22.0,Rash maculo-papular,16751106
0,6,22.0,Product use in unapproved indication,16751120
1,6,22.0,Acute kidney injury,16751120
0,2,22.0,Hyperglycaemia,16751146
1,2,22.0,Renal failure,16751146
0,6,22.0,Subacute cutaneous lupus erythematosus,16751207
0,5,22.0,Malignant neoplasm progression,16751299
1,6,22.0,Intentional product use issue,16751299
0,2,22.0,Osteonecrosis of jaw,16751348
0,6,22.0,Disease progression,16751364
1,6,22.0,Drug ineffective,16751364
2,6,22.0,Metastasis,16751364
0,5,22.0,Cardio-respiratory arrest,16751373
1,6,22.0,Hypoxic-ischaemic encephalopathy,16751373
2,6,22.0,Cardiac failure,16751373
3,5,22.0,Lung disorder,16751373
4,6,22.0,Oedema peripheral,16751373
0,3,22.1,Nausea,16751414
1,6,22.1,Weight decreased,16751414
2,6,22.1,Muscular weakness,16751414
3,6,22.1,Hypotension,16751414
4,6,22.1,Dry skin,16751414
5,6,22.1,Alopecia,16751414
6,6,22.1,Muscle twitching,16751414
7,6,22.1,Peripheral swelling,16751414
8,6,22.1,Dysgeusia,16751414
9,6,22.1,Decreased appetite,16751414
10,6,22.1,Fatigue,16751414
11,6,22.1,Myalgia,16751414
0,6,22.0,Hot flush,16751426
0,6,22.0,Decreased appetite,16751447
1,6,22.0,Panic reaction,16751447
2,5,22.0,Interstitial lung disease,16751447
3,6,22.0,Pneumothorax,16751447
4,6,22.0,Physical deconditioning,16751447
0,1,22.1,Delirium,16751454
0,5,22.1,Colon cancer,16751473
0,6,22.0,Pulmonary radiation injury,16751476
1,6,22.0,Swollen tongue,16751476
2,6,22.0,Pneumonia,16751476
0,5,22.1,Subdural haematoma,16751489
1,5,22.1,Subarachnoid haemorrhage,16751489
0,6,22.0,Dysphagia,16751515
1,6,22.0,Product dose omission,16751515
0,5,22.1,Death,16751526
1,3,22.1,Pain,16751526
2,3,22.1,Palliative care,16751526
0,5,22.0,Death,16751533
0,2,22.1,Eyelid oedema,16751546
1,1,22.1,Seizure,16751546
2,1,22.1,Anaphylactic shock,16751546
3,2,22.1,Ocular hyperaemia,16751546
4,1,22.1,Loss of consciousness,16751546
5,1,22.1,Blood pressure decreased,16751546
0,3,22.0,Body temperature increased,16751550
1,3,22.0,Pericardial haemorrhage,16751550
2,1,22.0,Decreased appetite,16751550
3,3,22.0,Red blood cell count decreased,16751550
0,2,22.0,Oesophageal ulcer,16751560
0,5,22.0,Death,16751584
0,5,22.0,Death,16751602
0,5,22.0,Death,16751643
0,6,22.1,Pyrexia,16751647
1,6,22.1,Hepatic enzyme increased,16751647
2,2,22.1,Rash pruritic,16751647
3,6,22.1,Diarrhoea,16751647
4,2,22.1,Rash,16751647
5,3,22.1,Dermatomyositis,16751647
6,6,22.1,Dry mouth,16751647
0,6,22.0,Neck mass,16751648
1,6,22.0,Abscess intestinal,16751648
2,6,22.0,Intestinal obstruction,16751648
3,6,22.0,Blood count abnormal,16751648
4,6,22.0,Fistula,16751648
0,3,22.0,Obstructive airways disorder,16751661
1,3,22.0,Respiratory failure,16751661
2,3,22.0,Mucosal toxicity,16751661
0,3,22.0,Renal tubular disorder,16751690
1,1,22.0,Hypocalcaemia,16751690
0,1,22.1,Full blood count decreased,16751730
0,6,22.0,Cardiac amyloidosis,16751734
0,2,22.0,Pneumonia,16751746
0,3,22.1,Hair disorder,16751755
1,6,22.1,Depression,16751755
2,3,22.1,Alopecia,16751755
3,3,22.1,Hair texture abnormal,16751755
4,3,22.1,Madarosis,16751755
5,3,22.1,Hair colour changes,16751755
0,6,22.0,Hair texture abnormal,16751757
1,3,22.0,Alopecia,16751757
2,6,22.0,Hair disorder,16751757
3,6,22.0,Hair colour changes,16751757
4,3,22.0,Madarosis,16751757
0,6,22.1,Ageusia,16751761
1,6,22.1,Taste disorder,16751761
2,6,22.1,Fungal skin infection,16751761
3,6,22.1,Yellow skin,16751761
4,6,22.1,Diarrhoea,16751761
5,6,22.1,Skin atrophy,16751761
6,6,22.1,Fungal infection,16751761
7,6,22.1,Photosensitivity reaction,16751761
0,6,22.0,Infectious pleural effusion,16751788
1,6,22.0,Pneumonia,16751788
0,1,22.1,Colitis ischaemic,16751789
0,2,22.0,Confusional state,16751798
1,2,22.0,Neutropenia,16751798
2,2,22.0,Hyponatraemia,16751798
0,2,22.0,Diarrhoea,16751823
0,3,22.1,Plasma cell myeloma,16751851
0,6,22.1,Osteopenia,16751883
1,6,22.1,Hypoaesthesia,16751883
2,6,22.1,Scab,16751883
3,1,22.1,Dyspnoea,16751883
4,6,22.1,Hypoaesthesia oral,16751883
5,2,22.1,Constipation,16751883
6,6,22.1,Platelet count decreased,16751883
7,6,22.1,Intestinal obstruction,16751883
8,6,22.1,Ascites,16751883
9,2,22.1,Back pain,16751883
10,6,22.1,Flatulence,16751883
11,1,22.1,Renal impairment,16751883
12,1,22.1,Hypertension,16751883
13,2,22.1,Haemoglobin decreased,16751883
14,3,22.1,Abdominal pain,16751883
15,6,22.1,Product dose omission,16751883
16,6,22.1,Transfusion,16751883
17,6,22.1,Skin disorder,16751883
18,3,22.1,Diarrhoea,16751883
0,1,22.0,Bone marrow failure,16751918
0,5,22.0,Death,16751922
0,5,22.0,Death,16751949
0,6,22.1,Headache,16752024
1,6,22.1,Fatigue,16752024
0,3,22.1,Blood creatine phosphokinase increased,16752191
0,1,22.0,Apnoea,16752275
1,1,22.0,Micturition disorder,16752275
2,1,22.0,Daydreaming,16752275
0,6,22.0,Renal failure,16752384
1,6,22.0,Liver function test abnormal,16752384
2,6,22.0,Dysgeusia,16752384
3,6,22.0,Musculoskeletal discomfort,16752384
4,6,22.0,Diarrhoea,16752384
5,6,22.0,Haematochezia,16752384
6,6,22.0,Myalgia,16752384
0,6,22.0,Blister,16752392
1,6,22.0,Skin ulcer,16752392
0,1,22.0,Dehydration,16752393
1,1,22.0,Diarrhoea,16752393
2,1,22.0,Vomiting,16752393
0,2,22.0,Hyperglycaemia,16752395
0,1,22.0,Cardiac failure congestive,16752414
0,3,22.1,Blood creatinine increased,16752415
1,6,22.1,Vomiting,16752415
2,6,22.1,Product use issue,16752415
3,3,22.1,Liver function test abnormal,16752415
4,3,22.1,Renal function test abnormal,16752415
0,1,22.0,Nausea,16752425
1,6,22.0,Concomitant disease aggravated,16752425
2,6,22.0,Gastrointestinal motility disorder,16752425
3,6,22.0,Blood urea decreased,16752425
4,6,22.0,Loss of consciousness,16752425
5,6,22.0,Urine leukocyte esterase positive,16752425
6,6,22.0,Diarrhoea,16752425
7,6,22.0,Peptic ulcer,16752425
8,6,22.0,Tachycardia,16752425
9,1,22.0,Blood potassium decreased,16752425
10,6,22.0,Weight decreased,16752425
11,2,22.0,Hypophagia,16752425
12,6,22.0,Decreased appetite,16752425
13,6,22.0,Hypotension,16752425
14,6,22.0,Vomiting,16752425
15,6,22.0,Asthenia,16752425
0,6,22.0,Infection,16752448
0,3,22.0,Muscle spasticity,16752455
1,3,22.0,Seizure,16752455
2,3,22.0,Withdrawal syndrome,16752455
0,3,22.0,Dry skin,16752474
1,3,22.0,Arthralgia,16752474
2,3,22.0,Visual impairment,16752474
3,3,22.0,Bone pain,16752474
4,6,22.0,Teeth brittle,16752474
5,2,22.0,Alopecia,16752474
6,3,22.0,Hot flush,16752474
7,3,22.0,Osteoporosis,16752474
0,6,22.0,Lip disorder,16752489
1,6,22.0,Chapped lips,16752489
2,6,22.0,Rash,16752489
3,6,22.0,Toxic epidermal necrolysis,16752489
4,6,22.0,Cheilitis,16752489
5,5,22.0,Staphylococcal infection,16752489
0,5,22.0,Vomiting,16752512
1,5,22.0,Blood pressure abnormal,16752512
2,5,22.0,Constipation,16752512
3,5,22.0,Intestinal obstruction,16752512
0,5,22.1,Acute myeloid leukaemia,16752513
1,5,22.1,Second primary malignancy,16752513
2,5,22.1,Cardiac arrest,16752513
3,5,22.1,Cardiotoxicity,16752513
0,6,22.1,Restlessness,16752531
1,5,22.1,Pain,16752531
2,6,22.1,Vomiting,16752531
3,6,22.1,Anxiety,16752531
4,5,22.1,Malignant neoplasm progression,16752531
5,1,22.1,Ascites,16752531
6,6,22.1,Nausea,16752531
0,1,22.1,Breast cancer recurrent,16752592
1,1,22.1,Leukopenia,16752592
2,6,22.1,Malignant neoplasm progression,16752592
3,1,22.1,Breast cancer metastatic,16752592
4,3,22.1,Anaemia,16752592
5,6,22.1,Asthenia,16752592
6,3,22.1,Fatigue,16752592
7,1,22.1,Neutropenia,16752592
0,6,22.1,Neutropenia,16752673
1,6,22.1,Off label use,16752673
2,6,22.1,Underdose,16752673
3,3,22.1,Renal impairment,16752673
4,1,22.1,Decreased appetite,16752673
5,1,22.1,Neutropenia,16752673
6,6,22.1,Dehydration,16752673
0,3,22.0,Neuropathy peripheral,16752684
1,3,22.0,Trigger finger,16752684
2,3,22.0,Neuropathy peripheral,16752684
0,6,22.0,Granulocytopenia,16752685
1,6,22.0,Invasive ductal breast carcinoma,16752685
2,6,22.0,Leukopenia,16752685
3,6,22.0,Haematocrit decreased,16752685
4,6,22.0,Bone marrow failure,16752685
5,6,22.0,Lymphopenia,16752685
6,6,22.0,Red blood cell count decreased,16752685
0,5,22.0,Death,16752714
0,5,22.0,Sedation,16752734
1,5,22.0,General physical health deterioration,16752734
2,5,22.0,Metastases to bone,16752734
3,5,22.0,Constipation,16752734
4,5,22.0,Breast cancer metastatic,16752734
5,5,22.0,Breakthrough pain,16752734
6,5,22.0,Disturbance in attention,16752734
7,5,22.0,Malignant neoplasm progression,16752734
8,5,22.0,Anxiety,16752734
9,5,22.0,Asthenia,16752734
0,6,22.0,Depression,16752836
1,6,22.0,Nausea,16752836
2,6,22.0,Rash,16752836
3,6,22.0,Asthenia,16752836
4,6,22.0,Diarrhoea,16752836
5,6,22.0,Fatigue,16752836
0,6,22.0,Compression fracture,16752909
1,6,22.0,Breast calcifications,16752909
2,6,22.0,Musculoskeletal chest pain,16752909
3,6,22.0,Intervertebral disc protrusion,16752909
4,6,22.0,Intervertebral disc degeneration,16752909
5,6,22.0,Bone marrow failure,16752909
0,6,22.0,Neoplasm progression,16752942
1,6,22.0,Haematotoxicity,16752942
0,1,22.1,Pyrexia,16752993
1,1,22.1,White blood cell count decreased,16752993
2,1,22.1,Neutrophil count decreased,16752993
3,2,22.1,Proteinuria,16752993
0,1,22.0,Urinary tract infection,16753098
0,5,22.1,Hepatic failure,16753111
1,6,22.1,Jaundice cholestatic,16753111
0,3,22.0,Hepatitis toxic,16753142
0,6,22.0,Ear swelling,16753174
1,6,22.0,Neutropenia,16753174
2,6,22.0,Pyrexia,16753174
3,2,22.0,Rash,16753174
4,2,22.0,Joint swelling,16753174
5,6,22.0,Immune-mediated adverse reaction,16753174
6,6,22.0,Thrombocytopenia,16753174
0,1,22.1,Duodenal ulcer haemorrhage,16753175
0,6,22.1,Spinal cord compression,16753191
0,5,22.1,Adenocarcinoma of the cervix,16753195
1,1,22.1,Genital haemorrhage,16753195
2,1,22.1,Pneumonia,16753195
0,3,22.0,Atrial fibrillation,16753205
0,6,22.0,Transaminases increased,16753246
1,6,22.0,Blood creatinine increased,16753246
0,2,22.0,Oropharyngeal pain,16753316
1,6,22.0,Dehydration,16753316
2,6,22.0,Prostatic specific antigen increased,16753316
3,6,22.0,Saliva discolouration,16753316
4,6,22.0,Blood pressure abnormal,16753316
5,6,22.0,Acquired diaphragmatic eventration,16753316
6,6,22.0,Pleural effusion,16753316
0,6,22.0,Blister,16753324
1,6,22.0,Skin ulcer,16753324
0,6,22.0,Dysphagia,16753326
0,2,22.0,Urogenital fistula,16753333
1,2,22.0,Post procedural bile leak,16753333
2,2,22.0,Gastrointestinal anastomotic leak,16753333
0,6,22.0,Stomatitis,16753372
1,6,22.0,Nephropathy toxic,16753372
2,6,22.0,Nausea,16753372
3,6,22.0,Vomiting,16753372
4,6,22.0,Neuropathy peripheral,16753372
5,6,22.0,Diarrhoea,16753372
6,6,22.0,Alopecia,16753372
7,6,22.0,Hepatotoxicity,16753372
0,6,22.0,Loss of consciousness,16753377
0,6,22.1,Aspiration,16753387
1,2,22.1,Cholangitis sclerosing,16753387
2,6,22.1,Bile duct stenosis,16753387
3,6,22.1,Pruritus,16753387
0,6,22.0,Condition aggravated,16753390
1,6,22.0,Drug ineffective,16753390
0,6,22.0,Malignant neoplasm progression,16753446
1,1,22.0,Cardiac disorder,16753446
2,6,22.0,Libido decreased,16753446
3,6,22.0,Hyperhidrosis,16753446
0,6,22.0,Dermatomyositis,16753455
0,1,22.0,Intracranial mass,16753497
1,1,22.0,Vision blurred,16753497
2,1,22.0,Metastases to central nervous system,16753497
3,1,22.0,Dry eye,16753497
0,3,22.1,Tooth fracture,16753506
1,6,22.1,Product use in unapproved indication,16753506
2,6,22.1,Drug ineffective,16753506
0,6,22.0,Unevaluable event,16753532
1,6,22.0,Bone marrow failure,16753532
2,6,22.0,Gastrointestinal disorder,16753532
3,6,22.0,Cardiotoxicity,16753532
4,6,22.0,Neuropathy peripheral,16753532
5,6,22.0,Hepatotoxicity,16753532
0,1,22.0,Neutropenia,16753553
1,1,22.0,Thrombocytopenia,16753553
2,1,22.0,Vomiting,16753553
3,3,22.0,Vomiting,16753553
4,1,22.0,Haematemesis,16753553
5,3,22.0,Diarrhoea,16753553
6,1,22.0,Pyrexia,16753553
0,2,22.1,Lung disorder,16753650
1,2,22.1,Lung disorder,16753650
0,6,22.0,Nephrolithiasis,16753680
1,6,22.0,Blood urine present,16753680
0,6,22.0,Lymphadenopathy,16753681
1,3,22.0,Ventricular extrasystoles,16753681
0,2,22.1,Pemphigoid,16753685
1,3,22.1,Interstitial lung disease,16753685
2,2,22.1,Autoimmune pancreatitis,16753685
3,1,22.1,Wound infection,16753685
0,1,22.0,Leukoencephalopathy,16753697
1,6,22.0,Blood pressure increased,16753697
0,6,22.0,Cardiac dysfunction,16753698
0,1,22.1,Hepatitis cholestatic,16753747
0,5,22.1,Metastases to adrenals,16753783
1,2,22.1,Haemolytic anaemia,16753783
0,6,22.0,Malignant neoplasm progression,16753793
1,2,22.0,Radiation pneumonitis,16753793
0,3,22.0,Renal tubular disorder,16753814
1,1,22.0,Hypocalcaemia,16753814
0,6,22.0,Malignant neoplasm progression,16753833
1,3,22.0,Diarrhoea,16753833
2,6,22.0,Diarrhoea,16753833
3,6,22.0,Headache,16753833
4,6,22.0,Menstrual disorder,16753833
5,6,22.0,Seasonal allergy,16753833
6,6,22.0,Sleep disorder,16753833
7,3,22.0,Body temperature increased,16753833
8,3,22.0,Alopecia,16753833
9,3,22.0,Abdominal pain,16753833
10,3,22.0,Rash pustular,16753833
11,3,22.0,Chest pain,16753833
12,6,22.0,Swelling,16753833
13,6,22.0,Nail disorder,16753833
14,6,22.0,Constipation,16753833
15,3,22.0,Diarrhoea,16753833
16,6,22.0,Back pain,16753833
17,6,22.0,Pharyngeal swelling,16753833
18,6,22.0,Oropharyngeal pain,16753833
19,6,22.0,Fatigue,16753833
20,6,22.0,Drug ineffective,16753833
21,6,22.0,Productive cough,16753833
22,3,22.0,Nipple pain,16753833
23,6,22.0,Neck pain,16753833
24,6,22.0,Muscle spasms,16753833
25,6,22.0,Chest pain,16753833
26,3,22.0,Stomatitis,16753833
27,3,22.0,Acne,16753833
28,6,22.0,Oropharyngeal discomfort,16753833
0,6,22.0,Dermatomyositis,16753841
0,1,22.0,Fall,16753854
1,1,22.0,Cognitive disorder,16753854
2,1,22.0,Cerebral amyloid angiopathy,16753854
3,1,22.0,Dementia,16753854
0,3,22.0,Colon cancer,16753856
0,6,22.1,Gallbladder disorder,16753900
1,3,22.1,Blister,16753900
2,3,22.1,Dehydration,16753900
3,3,22.1,Renal impairment,16753900
4,3,22.1,Blood pressure increased,16753900
5,2,22.1,Fatigue,16753900
6,2,22.1,Somnolence,16753900
7,3,22.1,Rash,16753900
0,5,22.0,Disease progression,16753902
0,6,22.0,Off label use,16753916
0,5,22.0,Death,16753921
0,5,22.0,Death,16753933
1,6,22.0,Neoplasm malignant,16753933
0,6,22.0,Thrombosis,16753966
1,2,22.0,Neutrophil count decreased,16753966
2,6,22.0,Depression,16753966
3,6,22.0,Peripheral venous disease,16753966
4,2,22.0,White blood cell count decreased,16753966
0,6,22.1,Foreign body in gastrointestinal tract,16753969
1,6,22.1,Cholelithiasis,16753969
2,6,22.1,Pain,16753969
0,6,22.0,Restlessness,16754018
1,6,22.0,Pain,16754018
2,6,22.0,Blood pressure increased,16754018
3,6,22.0,Anger,16754018
4,6,22.0,Blood glucose increased,16754018
5,6,22.0,Cataract,16754018
0,2,22.0,Hip fracture,16754019
0,6,22.0,Immune-mediated adverse reaction,16754030
1,6,22.0,Phlebitis,16754030
0,5,22.0,Hypotension,16754077
1,5,22.0,Stomatitis,16754077
2,5,22.0,Vomiting,16754077
3,5,22.0,Hypoxia,16754077
4,5,22.0,Tachycardia,16754077
5,5,22.0,Nausea,16754077
6,5,22.0,Productive cough,16754077
7,5,22.0,Arrhythmia,16754077
8,5,22.0,Hypophagia,16754077
9,5,22.0,Malaise,16754077
10,5,22.0,Neutropenic sepsis,16754077
11,5,22.0,Malaise,16754077
12,5,22.0,Oral candidiasis,16754077
13,5,22.0,Body temperature increased,16754077
14,5,22.0,Oropharyngeal pain,16754077
15,5,22.0,Tachypnoea,16754077
0,6,22.1,Pleural effusion,16754112
0,,22.1,Terminal state,16754143
0,1,22.0,Angioedema,16754171
1,1,22.0,Erythema,16754171
2,1,22.0,Oral pruritus,16754171
3,1,22.0,Cough,16754171
4,6,22.0,Off label use,16754171
5,1,22.0,Hypersensitivity,16754171
6,1,22.0,Malaise,16754171
7,1,22.0,Urticaria,16754171
0,6,22.0,Bone marrow failure,16754185
1,6,22.0,Oral infection,16754185
0,3,22.0,Osteonecrosis of jaw,16754196
1,6,22.0,Product use in unapproved indication,16754196
2,6,22.0,Off label use,16754196
0,6,22.0,Portal hypertension,16754204
1,6,22.0,Hepatic cirrhosis,16754204
0,1,22.0,Haemoglobin decreased,16754235
1,6,22.0,Malignant neoplasm progression,16754235
2,6,22.0,Bacterial infection,16754235
0,2,22.0,Autoimmune haemolytic anaemia,16754253
0,2,22.0,Uveitis,16754352
1,6,22.0,Osteoporosis,16754352
2,6,22.0,Osteonecrosis,16754352
0,,22.1,Abdominal pain upper,16754360
0,6,22.1,Hyperhidrosis,16754369
1,6,22.1,Nausea,16754369
2,6,22.1,Abdominal pain,16754369
3,6,22.1,Cholinergic syndrome,16754369
4,6,22.1,Off label use,16754369
5,6,22.1,Diarrhoea,16754369
6,6,22.1,Vomiting,16754369
7,6,22.1,Product use in unapproved indication,16754369
0,6,22.1,Asthenia,16754385
1,6,22.1,Gastroenteritis viral,16754385
2,6,22.1,Diabetes mellitus,16754385
3,6,22.1,Renal disorder,16754385
4,6,22.1,Feeling cold,16754385
5,2,22.1,Fatigue,16754385
6,6,22.1,Emotional disorder,16754385
7,6,22.1,Hypertension,16754385
8,3,22.1,Neoplasm progression,16754385
9,6,22.1,Tremor,16754385
0,5,22.0,Second primary malignancy,16754429
1,5,22.0,Acute lymphocytic leukaemia,16754429
0,,22.1,Death,16754447
0,3,22.0,Madarosis,16754453
1,3,22.0,Alopecia,16754453
0,,22.1,Death,16754475
0,1,22.0,Facial paralysis,16754479
1,1,22.0,Balance disorder,16754479
2,6,22.0,Activated partial thromboplastin time shortened,16754479
3,6,22.0,Blood creatinine increased,16754479
4,6,22.0,Haemoglobin decreased,16754479
5,6,22.0,High density lipoprotein decreased,16754479
6,1,22.0,Dizziness,16754479
7,6,22.0,Blood pressure increased,16754479
8,6,22.0,Blood urea decreased,16754479
9,1,22.0,Cerebrovascular accident,16754479
10,1,22.0,Dysarthria,16754479
0,,22.1,Urinary tract infection,16754502
1,,22.1,Blood disorder,16754502
2,,22.1,Infection,16754502
